MedPath

Investigation of the Effects of Discontinuing Beta Blockers on Exercise Tolerance in Patients with Chronic Myocardial Infarction and Preserved Left Ventricular Ejection Fractio

Not Applicable
Conditions
Chronic Myocardial Infarction with Preserved Left Ventricular Ejection Fraction&quot
Registration Number
JPRN-UMIN000052909
Lead Sponsor
Juntendo University Graduate School of Medicine
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Pending
Sex
All
Target Recruitment
100
Inclusion Criteria

Not provided

Exclusion Criteria

1. Individuals using implantable medical devices such as cardiac pacemakers or defibrillators. 2. Patients taking beta blockers for tachyarrhythmias. 3. Patients taking digitalis preparations, calcium channel blockers (verapamil, diltiazem), or ivabradine. 4. Patients diagnosed with acute phase of acute myocardial infarction, unstable angina not stable with medical treatment, uncontrolled arrhythmias causing symptoms or hemodynamic abnormalities, uncontrolled heart failure, uncontrolled hypertension, symptomatic severe aortic stenosis, or mental illness that precludes communication. Definition of heart failure symptoms: a) Dyspnea induced at rest or with mild exertion. b) At least two of the following: jugular venous distention, pulmonary rales, peripheral edema, or chest Xray showing pulmonary congestion. 5. Patients deemed unsuitable for the study by the principal investigator or co-investigator.

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Secondary Outcome Measures
NameTimeMethod
© Copyright 2025. All Rights Reserved by MedPath